Trypanosomiasis: Clinical Trials

2 trials for Trypanosomiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 31Terminated 1

Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
40 mg Atorvastatin/day for 120 days P.O., Atorvastatin 80, Placebo - Chronic Chagas Disease
Phase 2TerminatedJuan D. Maya3002021-10-122024-09-19
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Eflornithine plus Nifurtimox combination therapy - Trypanosomiasis, African
Phase 2 / Phase 3TerminatedEpicentre312002-10-012007-06-21

Narrower conditions

Chagas Disease (1)  ·  Inflammation (1)  ·  Trypanosomiasis, African (1)

Broader conditions

Euglenozoa Infections (2)  ·  Infections (2)  ·  Parasitic Diseases (2)  ·  Protozoan Infections (2)  ·  Vector Borne Diseases (2)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Eflornithine (1)

Sponsors

Epicentre (1)  ·  Juan D. Maya (1)

Countries

Chile (1)  ·  Uganda (1)

Top investigators

Gerardo Priotto, MD MPH (1)  ·  Juan D. Maya, Ph.D. (1)  ·  Patrice Piola, MD MSc (1)

Results publications

PMID 36638112